- Home
- AMTB vs DNA Comparison
AMTB vs DNA Comparison
Compare AMTB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTB
- DNA
- Stock Information
- Founded
- AMTB 1979
- DNA 2008
- Country
- AMTB United States
- DNA United States
- Employees
- AMTB N/A
- DNA N/A
- Industry
- AMTB Major Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMTB Finance
- DNA Health Care
- Exchange
- AMTB Nasdaq
- DNA Nasdaq
- Market Cap
- AMTB 792.0M
- DNA 895.1M
- IPO Year
- AMTB N/A
- DNA N/A
- Fundamental
- Price
- AMTB $17.31
- DNA $11.70
- Analyst Decision
- AMTB Buy
- DNA Strong Sell
- Analyst Count
- AMTB 4
- DNA 1
- Target Price
- AMTB $21.75
- DNA $9.00
- AVG Volume (30 Days)
- AMTB 301.1K
- DNA 1.4M
- Earning Date
- AMTB 10-28-2025
- DNA 11-06-2025
- Dividend Yield
- AMTB 2.10%
- DNA N/A
- EPS Growth
- AMTB N/A
- DNA N/A
- EPS
- AMTB 1.59
- DNA N/A
- Revenue
- AMTB $388,504,000.00
- DNA $230,815,000.00
- Revenue This Year
- AMTB $61.98
- DNA N/A
- Revenue Next Year
- AMTB $4.00
- DNA $14.41
- P/E Ratio
- AMTB $10.77
- DNA N/A
- Revenue Growth
- AMTB 51.98
- DNA 25.21
- 52 Week Low
- AMTB $15.62
- DNA $5.00
- 52 Week High
- AMTB $26.24
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- AMTB 39.51
- DNA 41.22
- Support Level
- AMTB $16.61
- DNA $11.83
- Resistance Level
- AMTB $17.68
- DNA $13.18
- Average True Range (ATR)
- AMTB 0.71
- DNA 0.89
- MACD
- AMTB -0.01
- DNA -0.24
- Stochastic Oscillator
- AMTB 48.33
- DNA 0.30
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.